Search Results 1281-1290 of 18513 for Prednisone

1. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   ... prednisone) or a single dose of systemic corticosteriods is eligible. Subject has prior severe allergic reaction or intolerance to known ingredients of ...

2. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   Treatment with prednisone >10 mg/day, azathioprine, hydroxychloroquine, colchizine, D-penicillamine, sulfasalazine, cyclophosphamide, rituximab, tocilizumab ...

3. Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA - Mayo Clinic

   ... (prednisone up to 20 mg/day or its equivalent is permitted for chronic conditions); Treatment with cytarabine at any dose, lenalidomide, or any other therapy ...

4. Protirelin (intravenous route) - Side effects & dosage - Mayo Clinic

   Protirelin is used to test the response of the anterior pituitary gland in people who may have certain medical conditions involving the thyroid gland. Testing ...

5. Danazol (oral route) - Side effects & dosage - Mayo Clinic

   Endometriosis. Fibrocystic breast disease (cysts in the breasts). Hereditary angioedema (swelling of the different parts of the body, such as abdomen or stomach ...

6. Vasodilators - Mayo Clinic

   The vasodilators that work directly on the blood vessel walls are: Hydralazine. Minoxidil. Some other medicines used to treat high blood pressure also help open ...

7. Pancreatic cancer - Care at Mayo Clinic

   Pancreatic cancer — Overview covers symptoms, risk factors, prevention, diagnosis, surgery, chemotherapy and other treatment for cancer of the pancreas.

8. Immunosuppressants · Cyclosporine (Gengraf, Neoral, Sandimmune). · Tacrolimus (Astagraf XL, Prograf, Envarsus XR).

9. A Study to Assess the Effectiveness and Safety of Durvalumab Alone or Combined with Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment - Mayo Clinic

   Systemic corticosteroids at physiologic doses not to exceed 10 mg/day of prednisone or its equivalent;; Steroids as pre-medication for hypersensitivity ...

10. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

    Systemic corticosteroids at doses that do not exceed 10 mg/day of prednisone or the equivalent;; Steroids as premedication for hypersensitivity reactions ...